Clinical Updates for Optometrists in the Diagnosis and Treatment of Neurotrophic Keratitis: A GameOn! Challenge

0.75 COPE

45 MINS

$0 FEE

SAVE

Overview

Provider Statement

This continuing education activity is provided by

Educational Partner Vindico Medical Education

Support Statement

This activity is supported by an educational grant from Dompé US, Inc.

Target Audience

The intended audience for this activity is optometrists and other health care professionals involved in the management of patients with neurotrophic keratitis.

Learning Objectives

Upon successful completion of this activity, participants should be better able to:

Evaluate the burden of neurotrophic keratitis, including pathophysiology, etiology, and modalities for early diagnosis of the condition.
Review clinical evidence for the current and emerging treatment options for neurotrophic keratitis.

Activity Co-chairs

John D. Sheppard, MD, MMSc
President, Virginia Eye Consultants
Professor of Ophthalmology, Microbiology &
Molecular Biology
Ophthalmology Residency Research Program Director
Clinical Director, Thomas R. Lee Center for Ocular Pharmacology
Eastern Virginia Medical School
Norfolk, VA

Walter O. Whitley, OD, MBA, FAAO
Consultative Optometrist
Eye Care Associates of Nevada
Sparks, NV

Reviewers

Ashay Bhatwadekar, PhD, RPh
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP

Accreditation

Purdue University is approved by the Council on Optometric Practitioner Education (COPE) as an administrator/provider of continuing education (CE).

Credit Designation

This enduring material is COPE-accredited for continuing education credits and is approved for one (1) year from the date of original release, June 15, 2022 to June 15, 2023.

COPE Course ID #: 78783-NO
COPE Event #: 124192

Please consult your state’s Board of Optometry to determine if the CE credit may apply toward your CE requirement for license renewal.

How to Participate in This Activity and Obtain CE Credit

To participate in this CE activity, you must read the objectives, answer the pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 70% of the posttest questions correctly. If a satisfactory score on the posttest is achieved, Purdue University will issue a CE Certificate.

Disclosures

Vindico Medical Education adheres to the Accreditation Council for Continuing Medical Education’s (ACCME) Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a continuing education activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Actvity Co-chairs report the following relationship(s)

John D. Sheppard, MD, MMSc
Consultant: AbbVie, Alcon, Aldeyra, Allergan, Bausch + Lomb, BioTissue, Claris Bio, Dompé, Eyedetec, EyeGate, EyePoint, Fortress Biotech, J&J Vision, Kala, LayerBio, Mallinckrodt, Mati, Novartis, Noveome, Ocular Therapeutix, Quidel, RPS, Tarsier Pharma, TearLab
Individual Stocks and Stock Options: Claris Bio, Eyedetec, EyeGate, EyeRx Direct, Fortress Biotech, LayerBio, Noveome, Mati, RPS, Strathspey Crown, TearLab

Walter O. Whitley, OD, MBA, FAAO
Consultant: Aerie, Alcon, Allergan, Bausch + Lomb, Bruder, Dompé, Eyenovia, Heru, I-MED Pharma, Kala, MediPrint, Oyster Point, Regener-Eyes, RVL, Santen, ScienceBased Health, Sun, Tarsus, Visus
Independent Research Contractor: Heru
Individual Stocks and Stock Options: MediPrint

Reviewers report the following relationship(s)

Ashay Bhatwadekar, PhD, RPh
No relevant financial relationships to disclose.

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.

Purdue University and Vindico Medical Education staff report the following relationship(s)

No relevant financial relationships to disclose.

Signed disclosures are on file at Purdue University and Vindico Medical Education, Office of Medical Affairs and Compliance.

Unlabeled and Investigational Usage

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)–approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.

Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2022 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Purdue University and Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Purdue University and Vindico Medical Education. Neither Purdue University and Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.